Assembly Biosciences Inc

Research Assembly Biosciences Inc (ASMB) on Bullrun: market cap USD 428.46M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerASMB
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 428.46M
• Financial periodFY2025
• RevenueUSD 72.30M
• Revenue growth153.5%
• Net income-USD 6.12M
• Free cash flow-USD 41.16M

Valuation Snapshot

latest market cap is USD 428.46M.

About Assembly Biosciences Inc

Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-5366 and ABI-1179, which are in Phase 1 clinical studies for recurrent genital herpes; and ABI-6250, an orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical study for the treatment of chronic hepatitis delta virus (HDV) infection.

Frequently asked questions

What is Assembly Biosciences Inc's market cap?

Assembly Biosciences Inc's market capitalization is USD 428.46M.

What does Assembly Biosciences Inc do?

Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide.